Navigation Links
Kendle Executive to Share Insights at World Pharma Trials Asia 2010
Date:3/17/2010

CINCINNATI, March 17 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced Dr. Ross Horsburgh, Vice President, Asia/Pacific will address the World Pharma Trials Asia 2010 conference being held March 17-18, 2010 at the Raffles City Convention Centre in Singapore. Dr. Horsburgh's presentation, "Accelerating Oncology Clinical Development in Asia," is scheduled for March 18 at 2 p.m. local time.  World Pharma Trials Asia brings together pharmaceutical companies, biotechnology companies and CROs to explore outsourcing opportunities in Asia.

Dr. Horsburgh's presentation will explore key opportunities and challenges in oncology development in the region, discuss the benefits of including Asian countries in global development plans for oncology, define key success factors for conducting these trials in Asia and discuss best practices in selecting the optimal sites for exploratory oncology trials.  

Following the conference, Dr. Horsburgh's presentation will be posted to the Kendle Web site at http://www.kendle.com/RW_media_show.php?cid=6.

Dr. Horsburgh is a trained medical physician with more than 20 years of experience in the CRO and pharmaceutical industries.  He is responsible for the strategic oversight of all of Kendle's operations throughout the Asia/Pacific region, which includes offices in Beijing, Hong Kong and Shanghai, China; Ahmedabad and New Delhi, India; Kuala Lumpur, Malaysia; Bangkok, Thailand; Manila, Philippines; Sydney and Melbourne, Australia and Singapore.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.

SOURCE Kendle International Inc.

Back to top

RELATED LINKS
http://www.kendle.com

'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate
2. Kendle Launches New Global Biostatistics Infrastructure
3. Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone
4. Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
5. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
6. Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition
7. Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
8. ThermalTherapeutic Systems, Inc. Announces the Addition of Former MEDRAD Executive Alan Hirschman, PhD to the Board of Directors
9. Yvonne Verburgt Joins the Avrio Executive Team as Vice President of Business Development and Marketing
10. Top Bristol-Myers Squibb Executive Joins Patton Boggs
11. Babson Executive Education Offers Bio-Pharma: Mastering the Business of Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)...  The Corporate Whistleblower Center says, "We are ... clinics to call us anytime at 866-714-6466 if they ... in a substantial scheme to overbill Medicare. We ... employee of a medical equipment company if their ... medical practice groups with extra generous incentives to use, ...
(Date:5/9/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... it has earned a spot on Forbes, ... was ranked among 500 U.S. employers as well as ... and Services. The annual Forbes ... survey of over 30,000 employees across 25 industries. The ...
(Date:5/9/2017)... PORTLAND, Ore. , May 9, 2017 /PRNewswire/ ... company that provides technology solutions to improve the ... reported financial results for the first quarter ended ... that our products enable our customers to identify ... them to intervene before events like heart attacks ...
Breaking Medicine Technology:
(Date:5/23/2017)... Santa Rosa, California (PRWEB) , ... May 23, ... ... population health management (PHM) technology and a 2017 Best in KLAS category winner, ... an advantageous market position to extend and enhance its technology platform and product ...
(Date:5/23/2017)... Las Vegas, NV (PRWEB) , ... May 23, ... ... with Significance Dental Specialists, are educating patients on peri-implantitis in Las ... new patients to receive a custom gum disease consultation and leading care for ...
(Date:5/23/2017)... ... May 23, 2017 , ... New patients with symptoms of gum ... now receive laser gum disease treatments from the doctors at Art of Dentistry, without ... raising awareness of the importance of receiving qualified treatment in order to avoid systemic ...
(Date:5/22/2017)... ... ... Patients who avoid necessary dental and endodontic treatments because of dental ... Advanced Endodontics of Westchester. This highly-trained team of endodontists offer three different sedation methods ... may be recommended based on the severity of the anxiety experienced by each patient. ...
(Date:5/22/2017)... ... 2017 , ... Galena, Alaska, has a population of less than 500 people. ... was targeted to build a nuclear plant by the TOSHIBA Corporation. , In “The ... Yoder describes the journey to get power to his small town, off the electrical ...
Breaking Medicine News(10 mins):